Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung Trial

Barlesi, F; Tomasini, P; Karimi, M; Michiels, S; Raimbourg, J; Daniel, C; Janicot, H; Madroszyk, A; Audigier-Valette, C; Quoix, E; Mazieres, J; Moro-Sibilot, D; Dansin, E; Molinier, O; Morel, H; Pichon, E; Cortot, A; Otto, J; Chomy, F; Souquet, PJ; Cloarec, N; Giroux-Leprieur, E; Bieche, I; Lacroix, L; Boyault, S; Attignon, V; Soubeyran, I; Morel, A; Tran-Dien, A; Jacquet, A; Dall'Olio, FG; Jimenez, M; Soria, JC; Besse, B

Barlesi, F (通讯作者)，Aix Marseille Univ, AP HM, Ctr Essais Precoces Cancerol Marseille Clip2, INSERM,CRCM,CNRS, F-13005 Marseille, France.

CLINICAL CANCER RESEARCH, 2022; 28 (18): 4018

Abstract

Purpose: Targeted therapies (TT) and immune checkpoint blockers (ICB) have revolutionized the approach to non-small cell lung cancer (NSCLC) treatment......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索